Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹1,163 Cr₹1,809 Cr₹867 Cr₹903 Cr₹807 Cr

What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA is ₹1,163 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹1,163 Cr
Mar2024₹1,809 Cr
Mar2023₹867 Cr
Mar2022₹903 Cr
Mar2021₹807 Cr

How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹1,163 Cr
-35.72
Mar2024 ₹1,809 Cr
108.67
Mar2023 ₹867 Cr
-4.01
Mar2022 ₹903 Cr
11.87
Mar2021 ₹807 Cr -

Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹71,415.2 Cr 1.8% 12.3% -1.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,044.0 Cr 1.5% 6.5% -1.5% Stock Analytics
DIVIS LABORATORIES ₹172,877.0 Cr 0.8% 0.3% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,042.0 Cr 1% 4.4% 18.1% Stock Analytics
CIPLA ₹123,060.0 Cr -0.4% -3.8% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,190.0 Cr 0.1% -2.8% 1.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.8%

12.3%

-1.3%

SENSEX

0.5%

1.7%

11%


You may also like the below Video Courses